Anthem Biosciences Limited (NSE:ANTHEM)

India flag India · Delayed Price · Currency is INR
670.20
+2.65 (0.40%)
Mar 5, 2026, 2:50 PM IST
Market Cap 374.90B
Revenue (ttm) 20.02B
Net Income (ttm) 4.85B
Shares Out 561.61M
EPS (ttm) 8.58
PE Ratio 77.84
Forward PE 55.87
Dividend n/a
Ex-Dividend Date n/a
Volume 95,908
Average Volume 267,087
Open 672.00
Previous Close 667.55
Day's Range 666.65 - 682.55
52-Week Range 579.15 - 873.50
Beta n/a
RSI 48.46
Earnings Date Feb 5, 2026

About Anthem Biosciences

Anthem Biosciences Limited operates as technology-focused contract research, development, and manufacturing organization. It operates through two segments: Contract Research, Development & Manufacturing (CRDMO) services; and Speciality Ingredients. The company offers end-to-end services across the new chemical entity and new biological entity lifecycles, including target identification and the concept stage; preclinical development; and manufacturing development batches of molecules used for clinical Phase I, II, and III trials up to commercial... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2006
Employees 1,963
Stock Exchange National Stock Exchange of India
Ticker Symbol ANTHEM
Full Company Profile

Financial Performance

In fiscal year 2025, Anthem Biosciences's revenue was 18.50 billion, an increase of 30.29% compared to the previous year's 14.20 billion. Earnings were 4.51 billion, an increase of 22.86%.

Financial Statements

News

There is no news available yet.